Clinical Trials Browser

Phase 1 × Immune Checkpoint Inhibitors × 30 days × Clear all

NCT04943848 2026-03-17

rHSC-DIPGVax Plus Checkpoint Blockade for the Treatment of Newly Diagnosed DIPG and DMG

Phase 1 Recruiting

Diffuse Intrinsic Pontine Glioma, Glioma

NCT04290546 2026-02-27

CIML NK Cell in Head & Neck Cancer

Phase 1 Completed

Squamous Cell Carcinoma of Head and Neck

NCT06524570 2026-02-18

iFOCUS

Phase 1 Recruiting

Neoplasm Metastasis, Neoplasms